Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
NCT06975410
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
EGFR Overexpression
Locally Advanced Solid Tumor
Metastatic Solid Tumor
Interventions
DRUG:
YH32364
Sponsor
Yuhan Corporation